PMID: 11901232Mar 20, 2002Paper

Effects of the anticonvulsant retigabine on cultured cortical neurons: changes in electroresponsive properties and synaptic transmission

Molecular Pharmacology
James F OttoKaren S Wilcox

Abstract

The whole-cell patch-clamp technique was used to examine the effects of retigabine, a novel anticonvulsant drug, on the electroresponsive properties of individual neurons as well as on neurotransmission between monosynaptically connected pairs of cultured mouse cortical neurons. Consistent with its known action on potassium channels, retigabine significantly hyperpolarized the resting membrane potentials of the neurons, decreased input resistance, and decreased the number of action potentials generated by direct current injection. In addition, retigabine potentiated inhibitory postsynaptic currents (IPSCs) mediated by activation of gamma-aminobutyric acid(A) (GABA(A)) receptors. IPSC peak amplitude, 90-to-10% decay time, weighted decay time constant, slow decay time constant, and, consequently, the total charge transfer were all significantly enhanced by retigabine in a dose-dependent manner. This effect was limited to IPSCs; retigabine had no significant effect on excitatory postsynaptic currents (EPSCs) mediated by activation of non-N-methyl-D-aspartate ionotropic glutamate receptors. A form of short-term presynaptic plasticity, paired-pulse depression, was not altered by retigabine, suggesting that its effect on IPSCs is pri...Continue Reading

References

Aug 1, 1981·Pflügers Archiv : European journal of physiology·O P HamillF J Sigworth
May 15, 1996·European Journal of Pharmacology·C ToberR Bartsch
Jan 1, 1997·Annual Review of Physiology·N V Marrion
Feb 7, 1998·Science·C BiervertO K Steinlein
Jan 5, 2000·European Journal of Pharmacology·R HetkaD Schmitz
Apr 13, 2000·The European Journal of Neuroscience·N HájosI Mody
Jul 25, 2000·Molecular Pharmacology·M J MainS A Burbidge
Aug 23, 2000·Molecular Pharmacology·A D WickendenP K Wagoner
Jun 28, 1954·The Journal of Physiology·J DEL CASTILLO, B KATZ

❮ Previous
Next ❯

Citations

Nov 13, 2012·Journal of Neurology·Snezana Maljevic, Holger Lerche
Apr 20, 2010·Pflügers Archiv : European journal of physiology·Snezana MaljevicHolger Lerche
Jul 2, 2008·Current Neurology and Neuroscience Reports·Michael A Rogawski, Carl W Bazil
Apr 9, 2013·European Journal of Pharmacology·William Dalby-BrownSusanne Jørgensen
Jan 3, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Brian S Meldrum, Michael A Rogawski
Mar 7, 2003·European Journal of Pharmacology·Clementina M van Rijn, Elly Willems-van Bree
Jan 1, 2010·Nature Reviews. Drug Discovery·Meir Bialer, H Steve White
Nov 26, 2003·The Journal of General Physiology·David L ProleNeil V Marrion
Jul 2, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·David KapfhamerUlrike Heberlein
Nov 1, 2011·Drugs·Cinzia Fattore, Emilio Perucca
Aug 20, 2014·Proceedings of the National Academy of Sciences of the United States of America·Tammy T NguyenJanet M Shaw
Dec 12, 2013·Pflügers Archiv : European journal of physiology·Alexej GrigorovSvetlana Fedulova
Apr 22, 2014·Brain : a Journal of Neurology·Christopher A ReidSteven Petrou
Sep 23, 2006·Expert Opinion on Investigational Drugs·Thomas V Wuttke, Holger Lerche
Jul 13, 2014·Epilepsy & Behavior : E&B·A M SlomkoL K Friedman
Feb 2, 2008·The Journal of Physiology·Snezana MaljevicHolger Lerche
May 16, 2009·Pharmacological Reports : PR·Jarogniew J Luszczki
Jan 24, 2009·Behavioural Brain Research·John P Redrobe, Alexander N Nielsen
Jan 19, 2005·British Journal of Pharmacology·Bruce A BamberErik M Jorgensen
Apr 1, 2009·Annals of Neurology·Yogendrasinh H RaolEdward C Cooper
Mar 21, 2009·British Journal of Pharmacology·David A Brown, Gayle M Passmore
Dec 23, 2011·British Journal of Pharmacology·Felicia KlingerStefan Boehm
Nov 28, 2012·British Journal of Pharmacology·A BoehlenC Gebhardt
Apr 16, 2013·British Journal of Pharmacology·L V Fretwell, J Woolard
May 24, 2011·Basic & Clinical Pharmacology & Toxicology·Majbrit M JensenJens D Mikkelsen
Apr 2, 2014·The Journal of Comparative Neurology·Chih H KingSteven S Scherer
Apr 20, 2006·Epilepsy Research·Michael A Rogawski
Sep 4, 2015·Nature Communications·Robin Y KimHarley T Kurata
Jul 27, 2011·NeuroImage·Felicia KlingerMark S Shapiro
Jul 13, 2012·Expert Opinion on Pharmacotherapy·Gökce OrhanHolger Lerche
Oct 22, 2002·Expert Opinion on Investigational Drugs·Collin A Hovinga
May 21, 2013·Seizure : the Journal of the British Epilepsy Association·L John Greenfield
Apr 1, 2014·European Journal of Pharmacology·Calvin WuErnest J Moore
Jan 25, 2014·European Journal of Pharmacology·Morten GrunnetPalle Christophersen
Feb 6, 2013·PloS One·Dhanya Parameshwaran, Upinder S Bhalla

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.